DETALUS ADVISORS, LLC – Eli Lilly and Company Transaction History
DETALUS ADVISORS, LLC portfolio value:
$0
portfolio value
DETALUS ADVISORS, LLC quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -741 shares | -240K | $323.35 | 0 |
| Q2 2022 | share | 0.00% | 0 shares | 28K | $324.23 | 741 | |
| Q1 2022 | share | Decrease | -11.89% | -100 shares | -20K | $286.37 | 741 |
| Q4 2021 | share | Increase | 0.00% | 841 shares | 232K | $277.25 | 841 |